Agnes K Indrati

Response to first-line antiretroviral treatment among human immunodeficiency virus-infected patients with and without a history of injecting drug use in Indonesia.

B. Alisjahbana, R. Wisaksana, P. Sudjana, 2010, Addiction.

Hepatitis B virus prevalence, risk factors and genotype distribution in HIV infected patients from West Java, Indonesia.

B. Alisjahbana, C. Boucher, M. Schutten, 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening

B. Alisjahbana, A. Meheus, R. van Crevel, 2010, Tropical medicine & international health : TM & IH.

Total lymphocyte count is a good marker for HIV‐related mortality and can be used as a tool for starting HIV treatment in a resource‐limited setting

B. Alisjahbana, R. Wisaksana, R. van Crevel, 2011, Tropical medicine & international health : TM & IH.

Total lymphocyte count is a reliable surrogate marker for CD4 cell counts after the first year of antiretroviral therapy: data from an Indonesian cohort study

B. Alisjahbana, R. Wisaksana, R. van Crevel, 2012, Tropical medicine & international health : TM & IH.

EFFECT OF HIV PREVENTION AND TREATMENT PROGRAM ON HIV AND HCV TRANSMISSION AND HIV MORTALITY AT AN INDONESIAN NARCOTIC PRISON.

B. Alisjahbana, A. Meheus, R. van Crevel, 2015, Southeast Asian Journal of Tropical Medicine and Public Health.

Virological failure and drug resistance during first line anti‐retroviral treatment in Indonesia

B. Alisjahbana, C. Boucher, M. Schutten, 2013, Journal of medical virology.